In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment
Journal of Controlled Release · 2023-07 · 359 · 69-84
DOI: 10.1016/j.jconrel.2023.05.034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-07. Verfasst von Youtao Xin und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Separation Membranes and Membrane Processes, School of Materials Science and Engineering, Tiangong University, Tianjin 300387…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Nanoparticles. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
The naturally evolved and intestinal pathogenic Fusobacterium nucleatum (Fn)-induced drug resistance profoundly impaired the efficacy of chemotherapy against colorectal cancer (CRC). Alternative treatment modalities against Fn-associated CRC are desperately needed. Herein, we engineer an in situ-activated anti-tumor and antibacterial nanoplatform (Cu2O/BNN6@MSN-Dex) to allow photoacoustic (PA) imaging-guided photothermal and NO gas combinatorial therapy for enhanced Fn-associated CRC treatment. The nanoplatform is constructed by loading cuprous oxide (Cu2O) and nitric oxide (NO) donor (BNN6) into dextran-decorated mesoporous silica nanoparticles (MSN), which is finally surface-functionalized with dextran via dynamic boronate linkage. Cu2O can be sulfuretted in situ by endogenous hydrogen sulfide overexpressed in CRC to produce copper sulfide with remarkable PA and photothermal properties, enabling the generation of NO from BNN6 under 808 nm laser irradiation, which is eventually triggered to release by multiple biological cues in the tumor microenvironment. Cu2O/BNN6@MSN-Dex exhibits superior biocompatibility, as well as H2S-triggered near-infrared-controlled antibacterial and anti-tumor performance in vitro and in vivo via photothermal and NO gas combination therapy. Furthermore, Cu2O/BNN6@MSN-Dex provokes systemic immune responses, thereby promoting anti-tumor efficacy. This study provides a conbinational strategy to effectively inhibit tumors and intratumor pathogens for enhanced CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Separation Membranes and Membrane Processes, School of Materials Science and Engineering, Tiangong University, Tianjin 300387, China.
- School of Biotechnology, Badr University in Cairo, Badr City, Cairo 11829, Egypt.
- State Key Laboratory of Separation Membranes and Membrane Processes, School of Materials Science and Engineering, Tiangong University, Tianjin 300387, China. Electronic address: huigao@tiangong.edu.cn.
Zitieren
APA
Xin, Y., Yu, Y., Su, M., Li, X., Elsabahy, M., & Gao, H. (2023). In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment. Journal of Controlled Release, 359, 69-84. https://doi.org/10.1016/j.jconrel.2023.05.034
Vancouver
Xin Y, Yu Y, Su M, Li X, Elsabahy M, Gao H. In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment. Journal of Controlled Release. 2023;359:69-84. doi:10.1016/j.jconrel.2023.05.034
BibTeX
@article{Xin2023,
author = {Xin, Youtao and Yu, Yunjian and Su, Meihui and Li, Xiaohui and Elsabahy, Mahmoud and Gao, Hui},
title = {In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment},
journal = {Journal of Controlled Release},
year = {2023},
volume = {359},
pages = {69--84},
doi = {10.1016/j.jconrel.2023.05.034}
}
EUVIMED